Log In
Print
BCIQ
Print
Print this Print this
 

StemEx, carlecortemcel-L

  Manage Alerts
Collapse Summary General Information
Company Gamida Cell Ltd.
DescriptionEx vivo expanded cord blood stem/progenitor cells in combination with non-expanded cells from the same cord blood unit
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$635.0M

$165.0M

$435.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today